Antimicrobial Resistance in Horses
Antimicrobial resistance (AMR) is a global problem with extremely complex epidemiology involving the direct and indirect transmission of antibiotic resistant pathogens and mobile genetic elements between humans, animals, and the environment. AMR is, therefore, recognized as a ‘One Health’ issue. Dat...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (124 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545774204498 |
---|---|
ctrlnum |
(CKB)5400000000041162 (oapen)https://directory.doabooks.org/handle/20.500.12854/68938 (EXLCZ)995400000000041162 |
collection |
bib_alma |
record_format |
marc |
spelling |
Steinman, Amir edt Antimicrobial Resistance in Horses Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (124 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Antimicrobial resistance (AMR) is a global problem with extremely complex epidemiology involving the direct and indirect transmission of antibiotic resistant pathogens and mobile genetic elements between humans, animals, and the environment. AMR is, therefore, recognized as a ‘One Health’ issue. Data that describe AMR prevalence and trends are required to enable the judicious and prudent use of antimicrobials in animals, which has implications both from veterinary and animal welfare aspects as well as from a zoonotic and public health perspective. Horses are a potential reservoir of AMR for humans due to close human–animal contact, as was demonstrated with shared human and horse methicillin-resistant Staphylococcus aureus (MRSA) strains causing outbreaks in equine hospitals. Extended-spectrum beta-lactamase-producing Enterobacteriaceae, considered as clinically and economically important to the AMR burden in human and veterinary medicine, has been reported in both community and clinic equine populations. Strains of Enterobacteriaceae pose a major worldwide threat due to the geographical expansion of ESBL-producing clones as well as the horizontal interspecies dissemination of ESBL-encoding plasmids and genes. In human medicine, ESBL-E infection is associated with increased morbidity, mortality, length of hospital stay, delay of targeted appropriate treatment, and higher costs. These issues also need to be addressed in horses. This Special Issue on AMR in horses encompasses several papers that describe the prevalence, risk factors, and molecular data on MDR bacteria in healthy horses in Canada, Japan, Spain, and Israel, in addition to papers that describe the clinical impact of MDR bacteria in diseased horses in Austria, USA, France and Israel. English Humanities bicssc Social interaction bicssc equine foal ESBL-E antibiotic resistance shedding umbilical infection risk factors healthy horses staphylococci MSSA ST1640 lukPQ ESBL Escherichia coli Enterobacteriaceae antimicrobial resistance CTX-M-1 SHV farm ESBL-E acquisition AmpC Klebsiella pneumoniae antibiotic-resistance β-lactamases horses extended-spectrum β-lactamase AmpC β-lactamase horse multidrug resistance beta-lactamase cephalosporinase microbiota North America horse pathogens epidemiology 3-03936-712-9 3-03936-713-7 Navon-Venezia, Shiri edt Steinman, Amir oth Navon-Venezia, Shiri oth |
language |
English |
format |
eBook |
author2 |
Navon-Venezia, Shiri Steinman, Amir Navon-Venezia, Shiri |
author_facet |
Navon-Venezia, Shiri Steinman, Amir Navon-Venezia, Shiri |
author2_variant |
a s as s n v snv |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Antimicrobial Resistance in Horses |
spellingShingle |
Antimicrobial Resistance in Horses |
title_full |
Antimicrobial Resistance in Horses |
title_fullStr |
Antimicrobial Resistance in Horses |
title_full_unstemmed |
Antimicrobial Resistance in Horses |
title_auth |
Antimicrobial Resistance in Horses |
title_new |
Antimicrobial Resistance in Horses |
title_sort |
antimicrobial resistance in horses |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (124 p.) |
isbn |
3-03936-712-9 3-03936-713-7 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT steinmanamir antimicrobialresistanceinhorses AT navonveneziashiri antimicrobialresistanceinhorses |
status_str |
n |
ids_txt_mv |
(CKB)5400000000041162 (oapen)https://directory.doabooks.org/handle/20.500.12854/68938 (EXLCZ)995400000000041162 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Antimicrobial Resistance in Horses |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796652236179243008 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03907nam-a2200757z--4500</leader><controlfield tag="001">993545774204498</controlfield><controlfield tag="005">20240124213537.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041162</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68938</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041162</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Steinman, Amir</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antimicrobial Resistance in Horses</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (124 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Antimicrobial resistance (AMR) is a global problem with extremely complex epidemiology involving the direct and indirect transmission of antibiotic resistant pathogens and mobile genetic elements between humans, animals, and the environment. AMR is, therefore, recognized as a ‘One Health’ issue. Data that describe AMR prevalence and trends are required to enable the judicious and prudent use of antimicrobials in animals, which has implications both from veterinary and animal welfare aspects as well as from a zoonotic and public health perspective. Horses are a potential reservoir of AMR for humans due to close human–animal contact, as was demonstrated with shared human and horse methicillin-resistant Staphylococcus aureus (MRSA) strains causing outbreaks in equine hospitals. Extended-spectrum beta-lactamase-producing Enterobacteriaceae, considered as clinically and economically important to the AMR burden in human and veterinary medicine, has been reported in both community and clinic equine populations. Strains of Enterobacteriaceae pose a major worldwide threat due to the geographical expansion of ESBL-producing clones as well as the horizontal interspecies dissemination of ESBL-encoding plasmids and genes. In human medicine, ESBL-E infection is associated with increased morbidity, mortality, length of hospital stay, delay of targeted appropriate treatment, and higher costs. These issues also need to be addressed in horses. This Special Issue on AMR in horses encompasses several papers that describe the prevalence, risk factors, and molecular data on MDR bacteria in healthy horses in Canada, Japan, Spain, and Israel, in addition to papers that describe the clinical impact of MDR bacteria in diseased horses in Austria, USA, France and Israel.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Humanities</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social interaction</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">equine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">foal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ESBL-E</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">shedding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">umbilical infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">healthy horses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">staphylococci</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MSSA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ST1640</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lukPQ</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ESBL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Escherichia coli</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Enterobacteriaceae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CTX-M-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SHV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">farm</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ESBL-E acquisition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AmpC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Klebsiella pneumoniae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic-resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">β-lactamases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extended-spectrum β-lactamase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AmpC β-lactamase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multidrug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">beta-lactamase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cephalosporinase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">North America</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horse pathogens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epidemiology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-712-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-713-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Navon-Venezia, Shiri</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinman, Amir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Navon-Venezia, Shiri</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-01-25 02:21:35 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338034820004498&Force_direct=true</subfield><subfield code="Z">5338034820004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338034820004498</subfield></datafield></record></collection> |